OPER Technology Limited is a biotechnology startup founded in 2014. The company is focused on developing and perfecting an innovative technology in nanomaterial-based personalized medicine. Their goal is to offer an inexpensive, real-time monitoring, precise, effective, and globally available medical technology to improve healthcare and clinical practices for patients with incurable diseases. This new core technology involves nanosurgery with real-time monitoring, enabling specific cell harvest, cell engineering, and specific drug delivery to target cells in the body. The potential beneficiaries of their technology include patients with neurological diseases, patients with other incurable diseases like cancers, as well as research laboratories and medical research institutes worldwide. OPER Technology Limited is committed to advancing medical technology and inspiring researchers with innovative medical technology solutions. While specific information about their headquarter and recent investments are not available, the potential for disruptive innovation in the field of nanomaterial-based personalized medicine makes OPER Technology Limited a company worth monitoring for potential investment opportunities.
There is no investment information
No recent news or press coverage available for OPER Technology Limited.
We care about your data, and we'd love to use cookies make your experience better.